Lophius Biosciences is a biotechnology company focusing on the development and marketing of innovative immune diagnostic systems to improve therapy control and personalized treatment of patients in the area of transplantation, infectious and autoimmune diseases.
The company’s developments are based on its expertise in cell-mediated immunity as well as on its proprietary T-activation and Reverse T Cell Technology platforms. Whereas the T-activation technology platform allows an efficient stimulation of a broad spectrum of clinically-relevant immune effector cells to accurately measure the cell-mediated immunity, the Reverse T Cell Technology platform can distinguish between active and memory T cells to develop innovative diagnostics. 
With its T-Track CMV leading product, based on T-activation technology, Lophius offers a sensitive, reliable and standardized CE-marked in vitro diagnostic solution to measure the functionality of CMV-specific cell-mediated immunity. T-Track CMV assists clinicians in the risk stratification of CMV disease in immunocompromised patients, toward an improved and individualized patient management.

Show more
TypePrivate
HQRegensburg, DE
Founded2002
Size (employees)11 (est)
Websitelophius.com
Lophius Biosciences was founded in 2002 and is headquartered in Regensburg, DE
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Lophius Biosciences

Bernd Merkl

Bernd Merkl

Chief Executive Officer (CEO) / Managing Director
Ludwig Deml

Ludwig Deml

Chief Scientific Officer (CSO)
Show more

Lophius Biosciences Office Locations

Lophius Biosciences has an office in Regensburg
Regensburg, DE (HQ)
13 Am Biopark
Show all (1)
Report incorrect company information

Lophius Biosciences Financials and Metrics

Summary Metrics

Founding Date

2002

Lophius Biosciences total Funding

$14.4 m

Lophius Biosciences latest funding size

$2.36 m

Time since last funding

2 years ago

Lophius Biosciences investors

Lophius Biosciences's latest funding round in March 2017 was reported to be $2.4 m. In total, Lophius Biosciences has raised $14.4 m
Show all financial metrics
Report incorrect company information

Lophius Biosciences Company Life and Culture

Report incorrect company information

Lophius Biosciences Frequently Asked Questions

  • When was Lophius Biosciences founded?

    Lophius Biosciences was founded in 2002.

  • Who are Lophius Biosciences key executives?

    Lophius Biosciences's key executives are Bernd Merkl and Ludwig Deml.

  • How many employees does Lophius Biosciences have?

    Lophius Biosciences has 11 employees.

  • Who are Lophius Biosciences competitors?

    Competitors of Lophius Biosciences include Guardant Health, ImaginAb and Orgenesis.

  • Where is Lophius Biosciences headquarters?

    Lophius Biosciences headquarters is located at 13 Am Biopark, Regensburg.

  • Where are Lophius Biosciences offices?

    Lophius Biosciences has an office in Regensburg.

  • How many offices does Lophius Biosciences have?

    Lophius Biosciences has 1 office.